SCHEMBL3267306

SCHEMBL3267306

Cc1cc(NS(=O)(=O)c2ccccc2Cl)cc(C)c1C=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 4/20 0.50
PGR P06401 1/20 0.50
ALDH1A1 P00352 2/20 0.48
GAA P10253 2/20 0.48
PKM P14618 1/20 0.48
ALOX15 P16050 1/20 0.48
HTT P42858 1/20 0.48
HSD17B10 Q99714 1/20 0.48
EDNRA P25101 2/20 0.47
BRD4 O60885 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 2/20 0.46
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3267775 0.84 PPARG (0.52) ALDH1A1HTTEDNRAMEN1KMT2A
SCHEMBL3272196 0.81 PGR (0.55) SLC22A12PGRALDH1A1GAAEDNRA
SCHEMBL3268117 0.81 L3MBTL1 (0.51) PGRALDH1A1GAAPKMALOX15
SCHEMBL3267594 0.78 CYTH2 (0.69) ALDH1A1GAAPKMALOX15HTT
SCHEMBL20575861 0.78 SLC22A12 (0.56) SLC22A12PGRALDH1A1GAAEDNRA
SCHEMBL22087596 0.78 EDNRA (0.50) SLC22A12PGRALDH1A1GAAPKM
SCHEMBL22087586 0.78 SLC22A12 (0.52) SLC22A12PGRALDH1A1GAABRD4
SCHEMBL13629320 0.77 SLC22A12 (0.54) SLC22A12PGRALDH1A1GAABRD4
SCHEMBL13615035 0.77 SLC22A12 (0.54) SLC22A12PGRALDH1A1GAABRD4
SCHEMBL10456537 0.76 PGR (0.65) SLC22A12PGRALDH1A1GAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1914229-B1 NOVEL CERCOSPORAMIDE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2010-06-16 EP disclosed
US-20090036492-A1 Novel Cercosporamide Derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-02-05 US disclosed
EP-1914229-A1 NOVEL CERCOSPORAMIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036492-A1 Novel Cercosporamide Derivative GPR119, CBR3, SLC5A2 SLC22A12 1010/4885PGR 4536/4885ALDH1A1 381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.